Back

GLP-1 RAs reduce mortality and cardiovascular events across the spectrum of treated patients: a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Pharmacotherapy Antidiabetic Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Mattia Galli

Sapienza University of Rome, Rome (Italy)

8 More presentations in this session

Presentation thumbnail
Discussant - Pharmacotherapy
Presentation thumbnail
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Ph2 Trial of Pacibekitug SC Quarterly or Monthly in Patients with Elevated hs-CRP and Chronic Kidney Disease: TRANQUILITY 90-Day Results
Professor D. Bhatt (New York City, US)
Presentation thumbnail
SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis
Doctor K. Dimitriadis (Athens, GR)
Abstract Video
Presentation thumbnail
Comparative effectiveness of angiotensin ii receptor blockers versus angiotensin-converting enzyme inhibitors in acute myocardial infarction
Doctor P. Sun (Tianjin, CN)
Abstract Video
Presentation thumbnail
Comparative effectiveness of GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis with intervention ranking
Doctor M. Rahman (Flushing, US)
Abstract Video

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Pharmacotherapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
The effect of Glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in type 2 diabetes mellitus patients with coronary artery disease
thumbnail
Congress Presentation
Association between intensity of glycemic control with GLP-1 receptor agonists and risk of atherosclerotic cardiovascular disease: a systematic review and meta-regression
thumbnail
Congress Presentation
Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources